Myomo Reveals its $100 Income Objective Throughout Investor Day
Myomo, Inc. (NYSE:MYO) is without doubt one of the 10 Greatest Small Cap Robotics Shares to Purchase Now. On June 18, the corporate held an Investor and Analyst Day to evaluate the corporate’s enterprise mannequin and long-term aspirations.
The corporate cited its Q1 FY2025 efficiency and talked about that its lead technology capabilities helped recuperate the challenges confronted earlier within the quarter. Myomo’s administration highlighted that potential MyoPro sufferers are an untapped market, and the corporate is but to succeed in saturation with its promoting.
Kutlayev Dmitry/Shutterstock.com
The corporate additionally introduced its aim of $100 million in annual income by 2028. Of this, $15 million of income is to return from worldwide prospects and $20 million from its O&P channel.
Myomo, Inc. (NYSE:MYO) is a wearable robotics firm that provides performance to sufferers affected by neurological issues and higher limb paralysis.
Whereas we acknowledge the potential of MYO as an funding, we imagine sure AI shares supply better upside potential and carry much less draw back danger. In case you’re searching for a particularly undervalued AI inventory that additionally stands to learn considerably from Trump-era tariffs and the onshoring development, see our free report on the greatest short-term AI inventory.
READ NEXT: 30 Shares That Ought to Double in 3 Years and 11 Hidden AI Shares to Purchase Proper Now.
Disclosure: None. This text is initially revealed at Insider Monkey.
